Alma Ventures Targets $40 Million for Mental Health VC Fund

Alma Ventures is raising $40 million for a venture capital fund dedicated exclusively to mental health, Globes reports. The figure is the single hardest fact in the story — and, as of this writing, nearly the only one the report discloses.

What do we actually know?

The headline fact: a $40 million target. That is a small fund by venture standards. For context, the median US venture fund raised in recent years has cleared several hundred million dollars, which puts Alma's vehicle at roughly one-tenth the size of a mid-market peer. Small funds mean small checks, and small checks mean early-stage bets.

The sector focus is mental health. That is the entire stated thesis. Mental health technology has attracted persistent investor interest since 2020, but it has also produced a graveyard of well-funded failures — a point any limited partner reviewing this pitch will weigh.

The geography, per the Globes report, is Israel. Globes is a longstanding Israel business publication, and the appearance of the story there signals the fundraise is being conducted, at least in part, in the Israeli market.

What is not said?

Here the record thins out. The Globes report, as surfaced, does not name the fund's general partners, its anchor investors, or its first close. No portfolio companies are cited. No target return, fee structure, or investment period appears in the available text.

That absence matters. A $40 million ask with no disclosed backers is a solicitation, not a closed fund. Venture fundraises at this size fail more often than they succeed, and a headline target is not a commitment. Until a first close is announced, the $40 million figure is aspirational arithmetic.

The report also does not say whether the fund will back Israeli startups exclusively or invest globally. For a sector fund this small, geography will largely determine deal flow — and determine how many shots the fund gets. At typical pre-seed and seed check sizes, a $40 million pool might fund somewhere between 20 and 40 companies; the exact number depends on reserves the report leaves unstated.

Why does a mental health-only fund raise eyebrows?

Sector-specific funds live and die on timing. Mental health startups drew record funding in 2021, then hit a sharp downturn as payer reimbursement, clinician burnout, and consumer churn undermined unit economics. Prominent failures followed. A new entrant betting $40 million on the category in the current market is making a contrarian call, whether it says so or not.

There is a credible case on the other side. Demand for mental health services continues to outstrip supply across most developed markets, and valuations in the category have reset far below their 2021 peaks. A disciplined buyer entering now buys cheaper than the last cohort did.

The takeaway in plain words: the fund thesis is plausible and the target is modest, but with no disclosed investors, partners, or closes, this is a plan on paper rather than a funded vehicle.

What happens next?

The operative milestone is a first close. If Alma Ventures announces anchor commitments, the $40 million target gains substance; if months pass without one, the target joins the long list of sector funds that never left the pitch deck. Limited partners, and founders counting on a new check-writer in mental health, should watch the close announcements — not the headlines.